Source:http://linkedlifedata.com/resource/pubmed/id/15028670
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2004-4-26
|
pubmed:abstractText |
Friedreich ataxia (FRDA), a progressive neurodegenerative disorder associated with cardiomyopathy, is caused by severely reduced frataxin, a mitochondrial protein involved in Fe-S cluster assembly. We have recently generated mouse models that reproduce important progressive pathological and biochemical features of the human disease. Our frataxin-deficient mouse models initially demonstrate time-dependent intramitochondrial iron accumulation, which occurs after onset of the pathology and after inactivation of the Fe-S dependent enzymes. Here, we report a more detailed pathophysiological characterization of our mouse model with isolated cardiac disease by echocardiographic, biochemical and histological studies and its use for placebo-controlled therapeutic trial with Idebenone. The Fe-S enzyme deficiency occurs at 4 weeks of age, prior to cardiac dilatation and concomitant development of left ventricular hypertrophy, while the mitochondrial iron accumulation occurs at a terminal stage. From 7 weeks onward, Fe-S enzyme activities are strongly decreased and are associated with lower levels of oxidative stress markers, as a consequence of reduced respiratory chain activity. Furthermore, we demonstrate that the antioxidant Idebenone delays the cardiac disease onset, progression and death of frataxin deficient animals by 1 week, but does not correct the Fe-S enzyme deficiency. Our results support the view that frataxin is a necessary, albeit non-essential, component of the Fe-S cluster biogenesis, and indicate that Idebenone acts downstream of the primary Fe-S enzyme deficit. Furthermore, our results demonstrate that Idebenone is cardioprotective even in the context of a complete lack of frataxin, which further supports its utilization for the treatment of FRDA.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Benzoquinones,
http://linkedlifedata.com/resource/pubmed/chemical/Iron-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Iron-Sulfur Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquinone,
http://linkedlifedata.com/resource/pubmed/chemical/frataxin,
http://linkedlifedata.com/resource/pubmed/chemical/idebenone
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0964-6906
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1017-24
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15028670-Animals,
pubmed-meshheading:15028670-Benzoquinones,
pubmed-meshheading:15028670-Cardiomyopathy, Dilated,
pubmed-meshheading:15028670-Disease Models, Animal,
pubmed-meshheading:15028670-Electrocardiography,
pubmed-meshheading:15028670-Friedreich Ataxia,
pubmed-meshheading:15028670-Iron-Binding Proteins,
pubmed-meshheading:15028670-Iron-Sulfur Proteins,
pubmed-meshheading:15028670-Mice,
pubmed-meshheading:15028670-Mitochondria,
pubmed-meshheading:15028670-Myocardium,
pubmed-meshheading:15028670-Oxidative Stress,
pubmed-meshheading:15028670-Ubiquinone
|
pubmed:year |
2004
|
pubmed:articleTitle |
Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
|
pubmed:affiliation |
Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/Université Louis Pasteur, Illkirch, CU de Strasbourg, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|